Related Experiment Video
Updated: Jan 20, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
Human recombinant neutralizing antibodies against hantaan virus G2 protein
Joachim Koch1, Mifang Liang, Iris Queitsch
1Hantavirus-Forschungsstelle der Heidelberger Akademie der Wissenschaften, Im Neuenheimer Feld 230, D-69120 Heidelberg, Germany. joachim.koch@em.uni-frankfurt.de
Abstract:
Old world hantaviruses, causing hemorrhagic fever with renal syndrome (HFRS), still present a public health problem in Asia and Eastern Europe. The majority of cases has been recorded in China. The aim of our study was to generate human recombinant neutralizing antibodies to a hantavirus by phage display technology. To preserve the structural identity of viral protein, the panning procedure was performed on native Hantaan (HTN) (76-118) virus propagated in Vero-E6 cells. In total, five complete human recombinant IgG antibodies were produced in a baculovirus expression system. All of them were able to completely neutralize HTN, and Seoul (SEO) virus in a plaque reduction neutralization test (PRNT). Three of these antibodies could also completely neutralize Dobrava (DOB) virus but not Puumala (PUU) virus. All antibodies bind to Hantaan virus G2 protein localized in the virus envelope. The sequence areas within the HTN (76-118)-G2 protein detected by five selected antibodies were mapped using peptide scans. Two partial epitopes, 916-KVMATIDSF-924 and 954-LVTKDIDFD-963, were recognized, which presumably are of paramount importance for docking of the virus to host cell receptors. A consensus motif 916-KVXATIXSF-924 could be identified by mutational analysis. The neutralizing antibodies to the most widely distributed hantaviruses causing HFRS might be promising candidates for the development of an agent for prevention and treatment of HFRS in patients.
Related Concept Videos
07:55Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:45A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
04:54Cell-Based AAV Neutralizing Antibody Assay: A Colorimetric Technique to Detect Neutralizing Antibodies Against Specific Adeno-Associated Viruses in Serum
03:20Generation of Influenza Virus Escape Variants against Neutralizing Antibodies
05:01An Assay to Measure the Neutralizing Antibody Titer Specific for Respiratory Syncytial Virus
05:33A Microneutralization Assay to Measure Neutralizing Antibody Titers in Human Serum

